Biotech industry shows growth despite uncertainty

The biotech sector is experiencing its third consecutive year of growth, with revenues increasing by over 12%. This resilience is notable given ongoing macroeconomic uncertainty and financing challenges. The industry is actively seeking a stable balance between continued expansion and the prevailing economic pressures. The EY 2026 Biotech Beyond Borders Report highlights these dynamics, suggesting a fundamentally strong underlying industry that is navigating a complex global landscape. Despite external headwinds, the sector demonstrates a capacity for sustained development and innovation.